Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 30 September 2025
Accepted: 4 December 2025
First Online: 8 January 2026
Conflict of interest
: S. Kasper served as a consultant or on advisory boards for Angelini, Biogen, Boehringer, Esai, Janssen, IQVIA, Mylan, Otsuka Inc., Recordati, Rovi and Schwabe and has served on speakers bureaus for Angelini, Aspen Farmaceutica S.A., Biogen, Janssen, Recordati, Schwabe, Servier and Sothema. M. Mairinger and G.M. Godbersen declare that they have no competing interests.
